Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) saw unusually-high trading volume on Thursday. Approximately 8,988 shares traded hands during mid-day trading, an increase of 172% from the average daily volume of 3,306 shares. The stock last traded at $12.3815 and had previously closed at $12.59.
Bavarian Nordic Trading Down 1.1%
The firm has a market capitalization of $2.96 billion, a PE ratio of 12.58 and a beta of 1.25. The company has a fifty day moving average price of $11.22 and a two-hundred day moving average price of $10.11.
Bavarian Nordic (OTCMKTS:BVNRY – Get Free Report) last released its quarterly earnings results on Friday, August 21st. The company reported $0.46 EPS for the quarter. The company had revenue of $316.47 million for the quarter. Bavarian Nordic had a return on equity of 11.97% and a net margin of 24.36%.
About Bavarian Nordic
Bavarian Nordic A/S is a Denmark-based biotechnology and vaccine company focused on developing, manufacturing and commercializing vaccines for infectious diseases. The company supplies products to government agencies, public-health organizations, healthcare providers and private-sector customers in markets around the world.
Its best-known product is JYNNEOS, also marketed as IMVANEX in Europe and IMVAMUNE in Canada, a non-replicating smallpox and mpox vaccine. Bavarian Nordic also offers vaccines for travelers and other infectious-disease risks, including products targeting rabies, tick-borne encephalitis, typhoid and cholera, as well as selected pediatric and adult immunization needs.
Founded in 1994 and headquartered in Copenhagen, Bavarian Nordic has expanded from a vaccine research company into an international commercial vaccine manufacturer.
Read More
- Five stocks we like better than Bavarian Nordic
- Constellation Energy’s Nuclear Expansion Gets a $5 Billion Opening, Not a Guarantee
- Plugging In: Vertiv Cashes In On AI Demand
- Visa’s Toll Booth Keeps Collecting, But the Price Is Rising
- Alphabet’s Cloud Is Paying Off—But the Bill for Building It Keeps Growing
Receive News & Ratings for Bavarian Nordic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bavarian Nordic and related companies with MarketBeat.com's FREE daily email newsletter.
